A detailed history of Cannon Financial Strategists, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Cannon Financial Strategists, Inc. holds 2,523 shares of JNJ stock, worth $392,250. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,523
Previous 2,334 8.1%
Holding current value
$392,250
Previous $366 Million 11.77%
% of portfolio
0.07%
Previous 0.08%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$145.48 - $167.38 $27,495 - $31,634
189 Added 8.1%
2,523 $409 Million
Q2 2024

Sep 10, 2024

BUY
$144.38 - $157.78 $384,195 - $419,852
2,661 New
2,661 $389 Million
Q1 2024

Oct 01, 2024

SELL
$155.22 - $162.74 $21,420 - $22,458
-138 Reduced 5.19%
2,523 $399 Million
Q4 2023

Oct 18, 2024

SELL
$145.6 - $158.88 $47,611 - $51,953
-327 Reduced 12.29%
2,334 $366 Million
Q3 2023

Oct 18, 2024

BUY
$155.75 - $174.48 $20,091 - $22,507
129 Added 5.55%
2,452 $382 Million
Q3 2023

Oct 02, 2024

SELL
$155.75 - $174.48 $361,807 - $405,317
-2,323 Closed
0 $0
Q1 2023

Oct 02, 2024

SELL
$151.05 - $180.26 $51,054 - $60,927
-338 Reduced 12.7%
2,323 $360 Million
Q4 2022

Oct 18, 2024

SELL
$160.2 - $179.79 $1,762 - $1,977
-11 Reduced 0.47%
2,323 $410 Million
Q3 2022

Oct 18, 2024

SELL
$161.33 - $179.52 $8,711 - $9,694
-54 Reduced 2.22%
2,373 $388 Million
Q2 2022

Oct 18, 2024

BUY
$168.19 - $186.01 $6,895 - $7,626
41 Added 1.72%
2,427 $431 Million
Q1 2022

Oct 18, 2024

BUY
$158.14 - $179.59 $8,539 - $9,697
54 Added 2.32%
2,386 $423 Million
Q4 2021

Oct 18, 2024

SELL
$155.93 - $173.01 $311 - $346
-2 Reduced 0.09%
2,332 $399 Million
Q2 2021

Oct 18, 2024

BUY
$159.48 - $171.07 $16,266 - $17,449
102 Added 4.57%
2,332 $384 Million
Q1 2021

Oct 02, 2024

BUY
$153.07 - $170.48 $341,346 - $380,170
2,230 New
2,230 $367 Million
Q4 2020

Oct 18, 2024

SELL
$137.11 - $157.38 $14,259 - $16,367
-104 Reduced 4.46%
2,230 $351 Million
Q4 2020

Oct 02, 2024

SELL
$137.11 - $157.38 $347,573 - $398,958
-2,535 Closed
0 $0
Q3 2020

Oct 02, 2024

SELL
$140.38 - $153.83 $17,687 - $19,382
-126 Reduced 4.74%
2,535 $377 Million
Q2 2020

Oct 18, 2024

SELL
$128.81 - $155.51 $128 - $155
-1 Reduced 0.04%
2,535 $356 Million
Q1 2020

Oct 18, 2024

SELL
$111.14 - $153.99 $16,559 - $22,944
-149 Reduced 5.55%
2,536 $333 Million
Q4 2019

Oct 18, 2024

BUY
$127.5 - $146.44 $44,752 - $51,400
351 Added 15.04%
2,685 $392 Million
Q4 2019

Oct 02, 2024

SELL
$127.5 - $146.44 $347,055 - $398,609
-2,722 Closed
0 $0
Q3 2019

Oct 02, 2024

BUY
$126.95 - $142.14 $139,264 - $155,927
1,097 Added 67.51%
2,722 $352 Million
Q2 2019

Oct 02, 2024

SELL
$131.15 - $144.24 $6,032 - $6,635
-46 Reduced 2.75%
1,625 $226 Million
Q1 2019

Oct 02, 2024

SELL
$125.72 - $139.79 $124,462 - $138,392
-990 Reduced 37.2%
1,671 $234 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Cannon Financial Strategists, Inc. Portfolio

Follow Cannon Financial Strategists, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.